Closed · HT9425-23-PRCRP-CDA · CFDA 12.420 · Discretionary
DoD Peer Reviewed Cancer, Career Development Award
Federal grant opportunity posted by Dept. of the Army -- USAMRAA, cataloged on Grants.gov.
- Varies
- Award range
- Closed
- Status
- August 10, 2023
- Close date
- 12
- Expected awards
The verdict
DoD Peer Reviewed Cancer, Career Development Award is a closed discretionary listing from Dept. of the Army -- USAMRAA that offered Varies by applicant across 12 expected awards. Future funding cycles may be published under the same CFDA number.
- Varies
- award range
- Closed
- application status
- 12
- expected awards
- 12.420
- CFDA program
Opportunity snapshot. This Grants.gov announcement - DoD Peer Reviewed Cancer, Career Development Award - is cataloged under number HT9425-23-PRCRP-CDA and tied to CFDA assistance listing 12.420, posted by Dept. of the Army -- USAMRAA. Grants.gov currently shows the opportunity as closed, first posted on April 4, 2023. The funding category is Discretionary, delivered as a grant.
Award economics. The award range on file is Varies by applicant. The agency has projected $76.8 million in total estimated funding for this announcement. It expects to issue 12 awards. If the agency funds the expected 12 awards from the $76.8 million estimated pool, the average award works out to roughly $6.4 million. Cost sharing is not required, so applicants do not need to commit matching funds to be competitive on this opportunity. Federal award ranges are often upper bounds; actual allocations reflect program appropriations, the strength of the applicant pool, and the evaluation committee's scoring.
Deadline and action path. This opportunity closed on August 10, 2023. Future funding cycles may be published under the same CFDA number, so monitoring the parent program page is the most reliable way to catch re-announcements. Every Grants.gov submission requires an active SAM.gov registration and a Unique Entity ID. Review the Eligibility section below carefully, federal eligibility categories (nonprofit, state or local government, tribal, individual, educational institution, small business) have distinct registration and reporting requirements. Pre-application outreach to the listed agency contact is permitted and often welcomed, it helps clarify scope and scoring priorities. Before acting on the deadline or award figures above, verify them directly on the official Grants.gov listing, amendments can change dates and amounts after this page was last refreshed.
Award Range
Varies by applicant
Close Date
August 10, 2023
Posted
April 4, 2023
Est. Total Funding
$76,800,000
Expected Awards
12
Instrument
Grant
Description
The PRCRP is seeking to advance cancer research through development of early-career investigators. Depending on the career path of the candidates, the PRCRP will offer two distinct early-career development options: the Career Development Award-Fellow Option (CDA-FO) and the Career Development Award-Resident Option (CDA-RO). Under this award mechanism, the early-career investigator is considered the Principal Investigator (PI), and the application should focus on the PI’s research and career development. The Career Development Award – Virtual Cancer Center Scholar Option is not being offered this fiscal year. Logical reasoning and a sound scientific rationale for the proposed research must be demonstrated. Preliminary data are not required. This award supports impactful research projects with an emphasis on discovery. · Fellow Option: The PI must be an early-career researcher or physician-scientist (referred to as a Fellow) within 7 years after completion of their terminal degree by the time of the application deadline (excluding time spent in residency, clinical training, or on family medical leave). PIs suitable for the Fellow Option include investigators who may not be on a tenure track and may share laboratory space not completely separate from a more established investigator. The intention of the Fellow Option is to support the early-career investigators toward wider independence and success. One research funding level is available for the Fellow Option. · Resident Option: The PI must be an early-career clinician during the time of their residency. PIs suitable for the Resident Option include investigators interested in a career path toward becoming a physician-scientist. The intention of the Resident Option is to support the early-career investigators research development with strong scientific career development. Two research funding levels are available for the Resident Option. The Resident must be able to commit 1 or 2 years within the time frame from approximately June 2024-2026 toward research with level of effort on the proposed research appropriate for the research funding level and the project. It is the responsibility of the PI to select the option that best aligns with their current career path. The option should be selected based on the eligibility defined in the program announcement. It is incumbent upon the early-career investigator to select the suitable option. The critical components of the Career Development Award: · Principal Investigator Fellow Option: The PI must be an early-career researcher or physician-scientist within 7 years after completion of their terminal degree by the time of the application deadline (excluding time spent in residency, clinical training, or on family medical leave). Time spent as a postdoctoral fellow is not excluded. Postdoctoral fellows are not eligible for this award mechanism. The PI’s record of accomplishments and the proposed research will be evaluated regarding their potential to contribute to at least one of the FY23 PRCRP Topic Areas in Section II.A.1. Previous and/or current career development funding outside of institutional startup funds will be taken into consideration when evaluating the need for further developmental funds. The Fellow Option is intended for candidates that have been named on only nominal career development funding. Applications are strongly encouraged to demonstrate protection of the PI’s time for cancer research. For more information on the eligibility criteria for the Fellow Option, refer to Section II.C.1. Resident Option: The PI must be an early-career clinician during the time of their residency. PIs suitable for the Resident Option include investigators interested in a career path toward becoming a physician-scientist. The Resident must articulate a clear plan to accomplish a scientifically rigorous project of either 1 year or 2 years. The PI must demonstrate a commitment to a career as an investigator at the forefront of one of the FY23 PRCRP Topic Areas and clinical practice; however, the PI is not required to have previous cancer research experience. Applications are strongly encouraged to demonstrate protection of the PI’s time for cancer research. Two research funding levels are available for the Resident Option. The Resident must be able to commit 1 or 2 years within the time frame from approximately June 2024-2026 toward research with level of effort on the proposed research appropriate for the research funding level and the project. Resident Research Level 1: A 1-year research project under the guidance of the designated Career Guide must be proposed. The 1-year research project application must include a hypothesis, objectives/aims, and experimental design. Research focused on early hypotheses or conceptual ideas are appropriate for Research Level 1. Resident Research Level 2: A 2-year research project under the guidance of the designated Career Guide must be proposed. The 2-year research project application must be more extensive and include a hypothesis, objectives/aims, an experimental design, and proposed outcomes. Research focused on more developed ideas and hypotheses are appropriate for Research Level 2. The Research Level chosen by the Resident must be justified by the complexity of the research project. It is incumbent upon the early-career investigator to select the suitable research level. · Career Guide: Both the Fellow and the Resident must designate a Career Guide. For the Fellow, the Career Guide must be an experienced cancer researcher, as demonstrated by a strong record of funding and publications. For the Resident, the Career Guide must be an experienced physician-scientist with a strong record of funding and publications in cancer. Under both options, the Career Guide must demonstrate a commitment to advancing the PI’s career in cancer research. · Career Development Plan Fellow Option: A individualized career development plan is required and should be prepared with appropriate guidance from the Career Guide. The career development plan should include a clearly articulated strategy for acquiring the necessary skills, competence, further independence, and expertise to advance their career at the forefront of cancer research in at least one of the FY23 PRCRP Topic Areas. Resident Option: An individualized career development plan is required and should be prepared with appropriate guidance from the Career Guide. The career development plan should include a clearly articulated strategy for acquiring the necessary skills, competence, and expertise that will enable the PI to successfully complete the proposed research project (level 1 or 2) and foster the PI’s development as an independent physician-scientist in at least one of the FY23 PRCRP Topic Areas. An environment appropriate to the proposed mentoring and research project must be clearly described. · Impact: The applicant must articulate the potential impact the proposed work will have on cancer research and/or patient care. Impactful research will accelerate the movement of promising ideas in cancer research into clinical applications. · Preliminary data are not required. Any preliminary data included in the application is subject to evaluation and review. Research proposed should be based on strong scientific reasoning and relevant literature.
Eligibility
Grants.gov lists this opportunity under eligibility category code 99. These codes correspond to applicant types (state/local government, tribal organization, nonprofit, educational institution, individual, small business, etc.) defined in Grants.gov's own eligibility reference. See the current Grants.gov eligibility categories or check the official listing below for this opportunity's exact eligibility statement.
Official Listing on Grants.gov
View full details, application forms, and submission instructions.
Agency Contact
CDMRP Help Desk Phone: 301-682-5507 Email: help@eBRAP.org
Key Dates
Frequently Asked Questions
What is this grant opportunity?
Is this opportunity still open?
How much funding is available?
How do I apply?
More from Dept. of the Army -- USAMRAA
BROAD AGENCY ANNOUNCEMENT (BAA) for Extramural Biomedical and Human Performance Research and Development Department of Defense
DOD Defense Health Agency (DHA) Research & Development FY23-FY27 BROAD AGENCY ANNOUNCEMENT for Extramural Medical Research
Department of Defense HIV/AIDS Prevention Program
Disclaimer: This information is sourced from Grants.gov and SAM.gov and is for informational purposes only. Opportunity details, deadlines, and eligibility requirements change frequently. Always verify current information directly on Grants.gov before applying. PlainGrants is not affiliated with any federal agency.
Read our methodology - how this data is sourced, computed, and verified.
Related
| Publisher | PlainGrants |
| Sources | the SAM.gov Assistance Listings and Grants.gov |